Publicaciones (42) Publicaciones de RICARDO GÓMEZ GARCÍA

2023

  1. A gain-of-function HCN4 mutant in the HCN domain is responsible for inappropriate sinus tachycardia in a Spanish family

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 120

  2. Structure of human CALHM1 reveals key locations for channel regulation and blockade by ruthenium red

    Nature Communications, Vol. 14, Núm. 1

2022

  1. Development and characterization of functional antibodies targeting NMDA receptors

    Nature Communications, Vol. 13, Núm. 1

2021

  1. NMDA receptor–BK channel coupling regulates synaptic plasticity in the barrel cortex

    Proceedings of the National Academy of Sciences, Vol. 118, Núm. 35, pp. e2107026118

2018

  1. Cereblon regulates BK channel expression at presynaptic and postsynaptic sites in excitatory synapses

    Journal of Neuroscience

2017

  1. Synapse-specific regulation revealed at single synapses is concealed when recording multiple synapses

    Frontiers in Cellular Neuroscience, Vol. 11

2016

  1. Activity-dependent switch of gabaergic inhibition into glutamatergic excitation in astrocyte-neuron networks

    eLife, Vol. 5, Núm. DECEMBER2016

  2. Nav1.5 N-terminal domain binding to α1-syntrophin increases membrane density of human Kir2.1, Kir2.2 and Nav1.5 channels

    Cardiovascular Research, Vol. 110, Núm. 2, pp. 279-290

  3. Pitx2c increases in atrial myocytes from chronic atrial fibrillation patients enhancing IKs and decreasing ICa,L

    Cardiovascular Research, Vol. 109, Núm. 3, pp. 431-441

2014

  1. Structural basis of drugs that increase cardiac inward rectifier Kir2.1 currents

    Cardiovascular Research, Vol. 104, Núm. 2, pp. 337-346

2013

  1. Chronic atrial fibrillation up-regulates β1-Adrenoceptors affecting repolarizing currents and action potential duration

    Cardiovascular Research, Vol. 97, Núm. 2, pp. 379-388

  2. Propafenone blocks human cardiac Kir2.x channels by decreasing the negative electrostatic charge in the cytoplasmic pore

    Biochemical Pharmacology, Vol. 86, Núm. 2, pp. 267-278

  3. p.D1690N Nav1.5 rescues p.G1748D mutation gating defects in a compound heterozygous Brugada syndrome patient

    Heart Rhythm, Vol. 10, Núm. 2, pp. 264-272

2011

  1. Functional effects of a missense mutation in HERG associated with type 2 long QT syndrome

    Heart Rhythm, Vol. 8, Núm. 3, pp. 463-470

2010

  1. Cardiac electrophysiological effects of nitric oxide

    Cardiovascular Research, Vol. 87, Núm. 4, pp. 593-600

  2. Clinical Pharmacology of Ranolazine, a Novel Compound for Treating Chronic Stable Angina

    Revista Espanola de Cardiologia Suplementos, Vol. 10, Núm. SUPPL. 2

  3. Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner

    Cardiovascular Research, Vol. 85, Núm. 1, pp. 56-67

  4. Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent manner

    Journal of Molecular and Cellular Cardiology, Vol. 48, Núm. 1, pp. 201-210

  5. Farmacología clínica de la ranolazina, un nuevo fármaco en el tratamiento de la angina crónica estable

    Revista Espanola de Cardiologia Suplementos, Vol. 10, Núm. 2, pp. 41-54

  6. Farmacología clínica de la ranolazina, un nuevo fármaco en el tratamiento de la angina crónica estable

    Revista Espanola de Cardiologia Suplementos, Vol. 10, Núm. 1